QIAGEN NV revenue for the last year amounted to 1.91 B EUR, the most of which — 723.42 M EUR — came from its highest performing source at the moment, Diagnostic Solutions, the year earlier bringing 632.03 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought QIAGEN NV 909.95 M EUR, and the year before that — 847.37 M EUR.